Patients with rheumatoid arthritis (RA) with synovial lymphocyte aggregates respond better to the anti-tumor necrosis factor (anti-TNF) agent infliximab than those with only diffuse leukocyte infiltration, researchers from the Netherlands report. Reuters Health Information
Like other chronic inflammatory arthropathies, SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome may require long-term antibiotic therapy. Arthritis Research & Therapy